WuXi PharmaTech’s Venture Unit Closes $290M Second Fund
December 15, 2015 — 10:23 CST
This Data Is Locked!
This area is available only to Subscribers.
WuXi Healthcare Ventures, the venture capital arm of New York Stock Exchange-listed pharmaceutical research and development services provider WuXi PharmaTech, has closed its second venture... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals